NSEOutcome of Board Meeting9 Jul 2026 · 9 Jul 2026, 07:38 pm
Outcome of Board Meeting
Virinchi Limited · VIRINCHI
✦ AI SummaryM&A
Virinchi Limited has informed the Exchange regarding Outcome of Board Meeting held on July 09, 2026. The board of directors met and approved the proposal to enter into a Business Transfer Agreement with Virinchi Health Care Private Limited for the acquisition of the Primary and Secondary Healthcare Business Division operated under the "Bristlecone Hospitals" brand, subject to the approval of shareholders.
Analysis Scores
Earnings Impact6/10
Growth Catalyst8/10
Governance Concern2/10
Regulatory Risk4/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Virinchi Limited has informed the Exchange regarding Outcome of Board Meeting held on July 09, 2026.
Attachments (1)
📄pdf
Download →
VIRINCHI1303_09072026193751_Outcome_of_Board_Meeting.pdf
View document text
9th July, 2026
To, To,
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex,
Dalal Street, Mumbai – 400001 Bandra (E), Mumbai - 400 051
Scrip Code: 532372 Symbol: VIRINCHI
Dear Sir/Madam,
Subject: Outcome of the Board Meeting – Regulation 30 of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015
With reference to the above subject, the board of directors met on today i.e 9th July, 2026
and approved the following transactions subject to the approval of shareholders.
1. Approved the proposal to enter into a Business Transfer Agreement (“BTA”) with
Virinchi Health Care Private Limited (“VHCPL”), a subsidiary of Virinchi Limited
(“Company”), for the acquisition of the Primary and Secondary Healthcare Business
Division operated under the “Bristlecone Hospitals” brand, together with all related
assets, liabilities, contracts, employees and other rights and obligations forming part of
the said business division, as a going concern on a slump-sale basis, subject to the
approval of the shareholders of the Company and receipt of such other regulatory,
statutory or other approvals, consents and permissions as may be required, with the
transaction being effective from April 1, 2026.
2. Approved the Postal ballot Notice
The meeting commenced at 6.30 p.m. and concluded at 7.15 p.m.
This is for your information and records.
Thanking you,
Yours faithfully,
For Virinchi Limited
K. Ravindranath Tagore
Company Secretary
M.No.A18894
In the context of the above, enclosed please find the relevant disclosure pursuant to
Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
read with the SEBI Master Circular dated 11th November, 2024.
S.No. Particulars Disclosures
1. Name of the target entity, M/s. Virinchi Health Care Private Limited (“VHCPL”),
details in brief such as size, a material subsidiary of M/s. Virinchi Limited,
turnover etc.; engaged in the business of healthcare services
under the brand name/style Bristlecone Hospitals
Located at Barkatpura and Hayathnagar,
Hyderabad. The healthcare undertaking proposed
to be acquired comprises the business operations
together with related assets, liabilities, contracts,
employees and other business undertakings, as a
going concern on a slump sale basis.
2. Whether the acquisition Yes. VHCPL is a material subsidiary of M/s. Virinchi
would fall within related party Limited and accordingly the proposed transaction
transaction(s) and whether falls within the ambit of related party transaction.
the promoter/ promoter The transaction is proposed to be undertaken on an
group/ group companies have arm’s length basis and in the ordinary course of
any interest in the entity being business, subject to applicable approvals under the
acquired? If yes, nature of Companies Act, 2013 and SEBI (Listing Obligations
interest and details thereof and Disclosure Requirements) Regulations, 2015.
and whether the same is done
at “arm’s length”;
3. Industry to which the entity Healthcare / Hospital and Medical Services Industry.
being acquired belongs;
4. Objects and impact of This restructuring is intended to establish a
acquisition (including but not dedicated AI-first healthcare platform while
limited to, disclosure of enabling Virinchi Hospitals to remain focused on
reasons for acquisition of tertiary and quaternary care. The proposal reflects
target entity, if its business is the Board's assessment that the future of
outside the main line of community healthcare will be increasingly driven by
business of the listed entity); Artificial Intelligence, digital operating systems,
standardized clinical pathways and scalable delivery
models. The Board considers this restructuring
proactive and aligned with long-term industry
evolution. It enables disciplined investment in AI,
software engineering, analytics, interoperability,
digital patient engagement, operational excellence
and standardized clinical governance. The resulting
platform is expected to improve patient outcomes,
physician productivity, affordability, scalability,
quality assurance and international
competitiveness. Virinchi Limited will also be able
to leverage common technology assets across
multiple hospitals, continuously refine AI models
using validated clinical workflows, and build
exportable intellectual property. The strategy
supports responsible innovation while maintaining
the highest standards of patient safety, ethics,
transparency and regulatory compliance. The long-
term aspiration is to establish Bristlecone Hospitals
as one of the world's leading AI-enabled community
healthcare brands originating from India.
5. Brief details of any The acquisition is subject to approval of
governmental or regulatory shareholders of the Company and such other
approvals required for the statutory, regulatory and contractual
acquisition; approvals/consents, as may be applicable.
6. Indicative time period for The acquisition is proposed to be completed within
completion of the acquisition; such period as may be mutually agreed between
the parties, subject to fulfilment of conditions
precedent and receipt of requisite approvals.
7. Consideration - whether cash The Company (listed entity) shall not be issuing any
consideration or share swap or securities or give any consideration in kind to
any other form and details of VHCPL. Loans and advances from Virinchi Limited to
the same; VHCPL will be adjusted against the consideration to
be paid by Virinchi Limited to VHCPL.
8. Cost of acquisition and/or the The Value of the transaction is Rs.100 Crores(
price at which the shares are Rupees One Hundred Crores)
acquired;
9. Percentage of shareholding / Not Applicable, as the transaction pertains to
control acquired and / or acquisition of healthcare business undertaking on a
number of shares acquired; slump sale basis and does not involve acquisition of
shares.
10. Brief background about the Virinchi Health Care Private Limited based in
entity acquired in terms of Telangana, India was incorporated on 16/12/2013.
products/line of business Purchase of the Primary and Secondary Healthcare
acquired, date of Business under Bristlecone Hospitals Brand from
incorporation, history of last 3 “VHCPL” as a going concern, on a ‘slump sale’ basis.
years turnover, country in The Turnover during last 3 years are 13,314.85
which the acquired entity has Lakhs, 10,414.98 Lakhs, 8,299.05 Lakhs respectively.
presence and any other
significant information (in
brief);